17 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
of assisting Board oversight of executive and director compensation. Without limiting the generality of the foregoing, the Compensation Committee has
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
of assisting Board oversight of executive and director compensation. Without limiting the generality of the foregoing, the Compensation Committee has
6-K
EX-99.2
XRTX
XORTX Therapeutics Inc
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
of the Committee is to assist Board oversight of:
the integrity of the Company’s financial statements;
the Company’s compliance with legal
6-K
EX-99.3
ha8bas57k
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
88lge5
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
xvpxa
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
1per1qtd
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
nmuv14ma zdfrfg
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
w9zgi6z4
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
q02u9 mqxsq58r
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
EX-15.2
728cdcrx5clwg
3 May 22
Annual report (foreign)
5:29pm
20-F
n1pe8fyttt2ekh85
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
rbaga9
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
yosf 8wy5k
23 Nov 21
Notice of Annual & Special Meeting of Shareholders
7:17am
- Prev
- 1
- Next